News

Ricerca offers a spectrum of services for the areas of agrochemical registration, environmental analysis and preclinical discovery and development for biopharmaceutical registration. Ricerca holds a current DEA license

According to the Astellas, Mirabegron is a once daily oral ß3-adrenoceptor agonist discovered and developed by the company. Mirabegron enhances the urine collection function by activating ß3-adrenoceptor on

Before joining MonoSol Rx, Dr Norvitch held many executive level positions in pharmaceutical and specialty pharmaceutical organisations. Most recently, she built the US regulatory function for ProStrakan, a

Cyntellec has said that Mr Zarrabian has been consulting with the company and has been acting CEO since March of 2010. Previously, he served as president and COO

The study was conducted at The Ohio State University Comprehensive Cancer Center, Arthur James Cancer Hospital and Richard Solove Research Institute (OSUCCC-James). Arno said that the primary objective

The Amnis new option AutoSampler is expected to enhance productivity by enabling unattended sample loading from a wide variety of 96 well plates. The AutoSampler includes standard-height and

Canadian Minister of Health is now free to issue an NOC to Apotex, if their regulatory submissions are in an approvable form, prior to the expiration of Nexium’s

UCB has released new data on Neupro, at the 14th International Congress of Parkinson’s Disease and Movement Disorders in Buenos Aires, Argentina, Neupro’s clinical data is investigated through

The data indicated that Arikace, delivered once daily for 28 consecutive days followed by 56 days off-treatment for four cycles, demonstrated improvement in lung function that was sustained